BMN 110 US Expanded Access Program
NCT01858103
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Mucopolysaccharidosis IVA
Morquio A Syndrome
MPS IVA
Interventions
DRUG:
BMN 110
Sponsor
BioMarin Pharmaceutical